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Epidemics of dengue fever (DF)/dengue hemorrhagic
fever (DHF) have been occurring in the South East Asian
Region (SEAR)1 and are considered to be an emerging
public health problem world over2. Dengue is an Aedes
transmitted viral infection caused by any of the four den-
gue virus serotypes (DENV 1–4) which belong to the
genus Flavivirus. This virus causes spectrum of mani-
festations ranging from DF to DHF and dengue shock
syndrome (DSS), which is fatal and usually associated
with secondary infections1.
In India, DF, DHF and DSS have been reported
from different parts of the country3–4. Port Blair is the
capital of Andaman and Nicobar Islands, an archipelago
of >500 islands and islets situated in the Bay of Bengal,
at a distance of 1200 km from the peninsular India. People
are constantly moving between mainland of India
and these islands. Dengue was not reported from
these islands5. However, patients with febrile DF, DHF
and DSS were reported for the first time in 20094. Subse-
quently, circulation of dengue serotypes 1 and 2 was es-
tablished6.
From mid-July 2013, medical and public health pro-
fessionals observed an increase in the number of febrile
cases with retro-orbital pain among the Wharf (a struc-
ture adjoining the harbour comprising a barrack housing
the security personnel) staff of Haddo area adjoining the
harbour in Port Blair. The Directorate of Health Services,
Andaman and Nicobar Administration requested to in-
vestigate the cause for the sudden increase in number of
febrile cases. In view of the clinical features suggestive
of dengue and widespread prevalence and infestation of
vector mosquitoes, dengue infection was suspected7–8. We
report the findings of the investigations undertaken among
the suspected cases (security personnel) residing in bar-
rack adjoining the harbour area.
A case definition for suspected DF was made based
on the symptoms/signs listed in WHO guidelines9. We
used a more inclusive case definition that mandated pres-
ence of any one of the symptoms/signs such as sudden
onset of fever, headache, retro-orbital pain, and myalgia
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for the diagnosis of probable case of dengue fever with
an aim to increase the sensitivity.
A total of 23 blood samples were collected from the
suspected patients after obtaining informed consent. All
the samples were tested for the presence of anti-DENV,
anti-chikungunya virus (CHIKV) IgM antibodies by IgM
capture ELISA kits developed by National Institute of
Virology (NIV), Pune10, and anti-leptospiral antibodies
by in-house developed microscopic agglutination test
(MAT) with a panel of known endemic antigens11. All
samples were also assessed for IgG antibodies by using
IgG capture ELISA (PanBio, France).
RNA was extracted from all the serum samples us-
ing Qiagen viral RNA extraction kit (Qiagen, USA) fol-
lowing manufacturer’s instructions. RT-PCR analysis was
carried out for the presence of DENV and CHIKV RNA
Table 1. IgM, IgG and RT-PCR results of the suspected and
confirmed patients
S.No. Lab. ID Age/Sex IgM ELISA IgG ELISA RT-PCR
1. HDW-01 40/M Positive Positive Negative
2. HDW-02 35/M Negative Negative Negative
3. HDW-03 55/M Negative Negative Negative
4. HDW-04 39/M Negative Negative Positive
5. HDW-05 42/M Negative Negative Positive
6. HDW-06 36/M Negative Negative Positive
7. HDW-07 25/M Negative Positive Positive
8. HDW-08 25/M Negative Negative Positive
9. HDW-09 24/M Negative Negative Positive
10. HDW-10 41/M Negative Negative Positive
11. HDW-11 31/M Positive Positive Negative
12. HDW-12 35/M Negative Negative Positive
13. HDW-13 40/M Negative Negative Negative
14. HDW-14 25/M Positive Positive Negative
15. HDW-15 42/M Negative Positive Negative
16. HDW-16 50/M Negative Negative Negative
17. HDW-17 24/M Negative Negative Negative
18. HDW-18 25/M Negative Negative Negative
19. HDW-19 53/M Negative Negative Positive
20. HDW-20 24/M Negative Positive Negative
21. HDW-21 44/M Negative Negative Positive
22. HDW-22 24/M Negative Positive Negative
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in all the samples by adopting standard protocol12–13.
Further, PCR product was purified and subjected to
DNA sequencing analysis. RT-PCR positive samples were
further subjected for virus isolation using Vero-E6 cell
lines14.
Of the 23 serum samples, 3 (13%) were found posi-
tive for DENV specific IgM antibodies. None of the
samples were positive for CHIKV IgM and leptospiral
antibodies. Of the 23 samples, 7 (30.4%) were positive
for IgG antibodies against dengue virus, 12 (52.1%)
samples were positive by RT-PCR analysis, amplified
PCR products with the size of 511 bp (Table 1). These
findings indicate that the aetiology of the infection was
due to DENV. No severe cases of DHF/DSS were ob-
served during the investigations. Patients confirmed to
be IgM positives and RT-PCR positive, met the criteria
Fig. 1:  Phylogenetic neighbour-joining tree showing eight Port Blair DENV sequences (HDW6F, HDW7F, HDW5F, HDW4F, HDW8F, HDW9F,
HDW10F and HDW12F) that have been grouped with DENV serotype-3 and genotype-III. J Vector Borne Dis 51, March 2014 60
of dengue fever case definition. The nucleotide sequenc-
ing of the 511 bp amplicon confirmed that the virus
sequence was homologous with DENV-3. The sequences
were submitted to the NCBI (Accession numbers
KF915030, KF915031, KF915032, KF915033,
KF915034, KF915035, KF915036 and KF915037). All
samples were negative for CHIKV RT-PCR analysis. Four
RT-PCR positive samples were subjected to culture, for
virus isolation but it was not successful.
Further, analyses were carried out by using maximum
composite likelihood model15 and MEGA516. The mean
pairwise genetic distance (K2P) between the nucleotide
sequences of dengue virus from Port Blair was zero per-
cent. The genetic distance between the dengue virus re-
ported in Delhi (EU846234; 2007) was K2P=0.015%. The
mean genetic distance between dengue reported during
the current investigation in Port Blair and serotype den-
gue-3 from worldwide was smaller (0.070%) than that of
dengue-1 (0.642%), dengue-2 (1.138%) or dengue-4
(1.356%) serotypes. The neighbour joining phylogenetic
tree analysis indicated that the dengue virus associated
with the sudden increase in febrile cases clustered with
genotype-III and the lineage III (Fig. 1).
Dengue outbreaks with different serotypes have been
reported in the mainland, India and also from Andaman
Nicobar Islands3, 6. Emergence of dengue serotype-3 in
north and south India has been reported in the
past17–18. Earlier studies showed the existence of dengue
serotype 1 and 2 in these islands6. The investigations from
the present study indicate circulation of third serotype of
dengue virus in the urban Port Blair. The current findings
are in consonance with the investigations reported else-
where18. Thus, it is evident that three serotypes are now
in circulation within the urban agglomeration of Port
Blair6. At this juncture, it is pertinent to mention that as
per the antibody-dependent enhancement hypothesis, sec-
ondary DENV infections are risk factors for DHF/DSS19.
Therefore, existence and circulation of multiple serotypes
in these islands could precipitate the frequency of occur-
rences with DSS/DHF. The detection of dengue-3 sero-
type could be due to introduction of a new serotype; else
it could be due to coincidental observation of the circu-
lating serotype. The current scenario warrants constant
vigil to monitor the situation coupled with a robust sur-
veillance component integrated with meteorological in-
formation and management of Aedes spp breeding sites
could prevent outbreaks in the future.
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